LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1848 | 5505 | 0.3357 | 0.0495 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4547 | 5505 | 0.8259 | 0.7510 |
BT-20 | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4811 | 5505 | 0.8740 | 0.8196 |
BT-20 | XL147 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4909 | 5505 | 0.8918 | 0.8451 |
BT-20 | Saracatinib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 3616 | 5505 | 0.6568 | 0.5090 |
BT-20 | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 5739 | 5505 | 1.0425 | 1.0608 |
BT-20 | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 1657 | 3676 | 5505 | 0.6677 | 0.5245 |
BT-20 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4606 | 5505 | 0.8367 | 0.7663 |
BT-20 | SU11274 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4682 | 5505 | 0.8505 | 0.7860 |
BT-20 | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 3869 | 5505 | 0.7029 | 0.5748 |
BT-20 | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 5556 | 5505 | 1.0091 | 1.0131 |
BT-20 | Torin1 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1240 | 5505 | 0.2252 | -0.1086 |
BT-20 | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1050 | 5505 | 0.1908 | -0.1578 |
BT-20 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1627 | 5505 | 0.2955 | -0.0080 |
BT-20 | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4154 | 5505 | 0.7545 | 0.6487 |
BT-20 | TWS119 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 4467 | 5505 | 0.8114 | 0.7301 |
BT-20 | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 1657 | 5138 | 5505 | 0.9332 | 0.9045 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1657 | 907 | 5505 | 0.1649 | -0.1949 |
BT-20 | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 1657 | 901 | 5505 | 0.1637 | -0.1966 |
BT-20 | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 2216 | 5505 | 0.4025 | 0.1451 |
BT-20 | WZ3105 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 1370 | 5505 | 0.2490 | -0.0746 |
BT-20 | XMD11-50 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 3453 | 5505 | 0.6272 | 0.4666 |
BT-20 | Y39983 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4304 | 5505 | 0.7818 | 0.6878 |
BT-20 | YM 201636 | 3.33 | uM | LJP5 | 72 | hr | 1657 | 3958 | 5505 | 0.7189 | 0.5978 |
BT-20 | ZSTK474 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1697 | 5505 | 0.3083 | 0.0103 |